Chinese medicinal composition for treating coronary heart disease

A composition and technology for coronary heart disease, applied in the directions of drug combinations, cardiovascular system diseases, pharmaceutical formulations, etc., can solve the problems of inability to be widely popularized, unacceptable to patients, unstable in curative effect, etc., and achieve good long-term effects, unique curative effects, The effect of fewer complications

Inactive Publication Date: 2011-06-01
孙华清
View PDF1 Cites 20 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, there are many ways to treat coronary heart disease at home and abroad. For example, the main treatment method of western medicine is to expand the coronary artery, and the second is to prevent the formation of thrombus and the accumulation of thrombus, resulting in narrowing of the lumen and reduction of blood flow. The curative effect is u

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chinese medicinal composition for treating coronary heart disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] Moxibustion astragalus 30g, Codonopsis 15g, moxibustion licorice 10g, whole melon 30g, scallion 30g, safflower 10g, Chuanxiong 15g, Wulingzhi 15g, salvia miltiorrhiza (stir-fried with wine) 20g, milletus 20g, motherwort 30g, pinellia 12g , Chenpi 10g, Guizhi 10g, Alisma 20g, Atractylodes 15g, Citrus aurantii 12g, Ophiopogon japonicus 12g, dry and grind into very fine powder, pass through a 300 mesh sieve, put into 1# capsules, and make Chinese medicine tablets for treating coronary heart disease agent.

Embodiment 2

[0050] Moxibustion Astragalus 40g, Codonopsis 15g, moxibustion licorice 12g, whole melon 30g, scallion 30g, safflower 10g, Chuanxiong 15g, Wulingzhi 15g, salvia miltiorrhiza (wine fried) 30g, Milletus 30g, motherwort 30g, Pinellia 15g , Chenpi 12g, Guizhi 10g, Alisma 30g, Atractylodes 15g, Citrus aurantii 12g, Ophiopogon japonicus 12g, dry and grind into very fine powder, pass through a 300-mesh sieve, and make tablets, which are Chinese medicine capsules for treating coronary heart disease.

[0051] This example is an embodiment of the best solution.

Embodiment 3

[0053] Moxibustion astragalus 30g, Codonopsis 12g, moxibustion licorice 10g, whole melon 30g, scallion 20g, safflower 6g, Chuanxiong 15g, Wulingzhi 10g, salvia miltiorrhiza (wine fried) 20g, Milletus 30g, motherwort 30g, Pinellia 15g , Chenpi 12g, Guizhi 6g, Alisma 30g, Atractylodes 15g, Citrus aurantii 12g, Ophiopogon japonicus 10g, dry and grind into very fine powder, pass through a 300-mesh sieve, and make an oral liquid, that is, an oral liquid for treating coronary heart disease.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a Chinese medicinal composition for treating coronary heart disease. The Chinese medicinal composition is a preparation prepared from the following raw materials: cauterized astragalus, codonopsis pilosula, cauterized liquoric root, snakegourd fruit, longstamen onion bulb, safflower, szechuan lovage rhizome, trogopterus dung, root of red-rooted salvia heated with liquor, suberect spatholobus stem, motherwort herb, processed rhizoma pinelliae, tangerine peel, cassia twig, oriental waterplantain rhizome, atraotydin, bitter orange and dwarf lilyturf tuber. The formula is suitable for vitality deficiency and phlegm stasis congesting type coronary heart diseases which are common clinically. Clinical verification of clinical 1,486 patients shows that the Chinese medicinal composition has quick response, exact curative effects, high efficiency, a small number of complications and good long-term effects, is economical and practical, is easily accepted by patients and has certain scientificity, advancement and practicability. The raw materials of the Chinese medicinal composition have wide sources, high quality and low price, so that the Chinese medicinal composition is worthy of popularizing in basic levels.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for treating coronary heart disease, in particular to an oral preparation prepared from Chinese herbal medicines. Background technique [0002] Coronary heart disease is a frequently-occurring disease and a common disease in clinical practice. Its pathological changes are characterized by recurrent pain behind the sternum, which can spread to the precordial area, and the pain is squeezed or stuffy, suffocating pain, and radiates to the left shoulder and the inner side of the left upper limb. Radiation is often induced by factors such as fatigue, emotional agitation, exposure to cold, and smoking. It is mainly caused by insufficient coronary blood supply, resulting in myocardial ischemia. Clinical symptoms caused by temporary ischemia and hypoxia. Traditional Chinese medicine believes that this disease belongs to The categories of "sinceral pain", "jue heart pain" and "chest pain" have ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8968A61P9/10A61K35/24
Inventor 孙华清徐韬王领台赵厚珍
Owner 孙华清
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products